Gaucher Disease: New Molecular Approaches to Diagnosis and Treatment
- 8 May 1992
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 256 (5058) , 794-799
- https://doi.org/10.1126/science.256.5058.794
Abstract
Gaucher disease is characterized by the accumulation of glucocerebroside, leading to enlargement of the liver and spleen and lesions in the bones. It is caused by an inherited deficiency of the enz...Keywords
This publication has 45 references indexed in Scilit:
- Creating the Costliest Orphan:The Orphan Drug Act in the Development of Ceredase™International Journal of Technology Assessment in Health Care, 1992
- Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher diseaseFEBS Letters, 1991
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- A Mutation in the Human Glucocerebrosidase Gene in Neuronopathic Gaucher's DiseaseNew England Journal of Medicine, 1987
- Hexosaminidase A deficiency in adultsAmerican Journal of Medical Genetics, 1986
- Bone-Marrow Transplantation in Severe Gaucher's DiseaseNew England Journal of Medicine, 1984
- Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylationBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- The uptake of agalacto‐glucocerebrosidase by rat hepatocytes and kupffer cellsFEBS Letters, 1978
- The uptake of native and desialylated glucocerebrosidase by rat hepatocytes and Kupffer cellsBiochemical and Biophysical Research Communications, 1978
- Tissue Acid Hydrolase Activities in Gaucher's DiseaseScandinavian Journal of Clinical and Laboratory Investigation, 1968